Advertisement
U.S. Markets closed
S&P Futures
5,885.75 -10.50 (-0.18%) Dow Futures
43,120.00 -57.00 (-0.13%) Nasdaq Futures
20,461.50 -58.00 (-0.28%) Russell 2000 Futures
2,249.50 -6.00 (-0.27%) Crude Oil
70.30 -0.26 (-0.37%) Gold
2,743.80 +4.90 (+0.18%)
Ensysce Biosciences, Inc. (ENSC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.86M |
| Enterprise Value | 2.27M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.58 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.50 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.85 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 2.0600 |
| 52 Week Low 3 | 0.1410 |
| 50-Day Moving Average 3 | 0.3207 |
| 200-Day Moving Average 3 | 0.6413 |
Share Statistics
| Avg Vol (3 month) 3 | 2.1M |
| Avg Vol (10 day) 3 | 1.92M |
| Shares Outstanding 5 | 13.87M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 8.36M |
| % Held by Insiders 1 | 1.54% |
| % Held by Institutions 1 | 4.41% |
| Shares Short (Sep 30, 2024) 4 | 180.22k |
| Short Ratio (Sep 30, 2024) 4 | 0.54 |
| Short % of Float (Sep 30, 2024) 4 | 2.09% |
| Short % of Shares Outstanding (Sep 30, 2024) 4 | 2.04% |
| Shares Short (prior month Aug 30, 2024) 4 | 689.39k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,075.62% |
Management Effectiveness
| Return on Assets (ttm) | -131.94% |
| Return on Equity (ttm) | -427.89% |
Income Statement
| Revenue (ttm) | 1.44M |
| Revenue Per Share (ttm) | 0.27 |
| Quarterly Revenue Growth (yoy) | -62.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -11.28M |
| Diluted EPS (ttm) | -2.7000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.04M |
| Total Cash Per Share (mrq) | 0.12 |
| Total Debt (mrq) | 454.46k |
| Total Debt/Equity (mrq) | 30.72 |
| Current Ratio (mrq) | 1.88 |
| Book Value Per Share (mrq) | 0.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9.78M |
| Levered Free Cash Flow (ttm) | -5.39M |
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.